NMRA
Neumora Therapeutics Inc.
$3.02
+$0.09(+3.07%)
60
Overall
60
Value
91
Tech
31
Quality
Market Cap
$419.44M
Volume
4.58M
52W Range
$0.61 - $14.09
Target Price
$7.00
EPS Estimates Overview
| Current Quarter | $-0.34 | Next Quarter | $-0.35 |
| Current Year | $-1.43 | Next Year | $-1.08 |
| QoQ Growth | -2.9% | YoY Growth | +24.5% |
| 3Y EPS CAGR | N/A | Target Price | $7.00 |
| Consensus | Buy | Upside | +131.8% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NMRA | $3.02 | +3.1% | 4.58M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Neumora Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW